Evidence map›Paper›PMID 8214007›Full record

ArticleThe American journal of pathology1993

Analysis of p60 and p80 tumor necrosis factor-alpha receptor messenger RNA and protein in human placentas.

K K Yelavarthi, J S Hunt

Open access · greenAbstract read
In one paragraph

Article in The American journal of pathology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

K K YelavarthiDepartment of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City 66160-7400.
J S Hunt
University of Kansas Medical Center · US

Funding

Research Design and Analysis Core (RDAC)P30HD002528 · NICHD · UNIVERSITY OF KANSAS LAWRENCE · PI DURHAM, DIANNE NONE · 1985 to 2015
$22.1M
DECIDUAL CELL/PLACENTAL INTERACTIONSR01HD024212 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HUNT, JOAN SHERAR · 1994 to 2007
$1.7M
ROLE OF TUMOR NECROSIS FACTOR-ALPHA IN DEVELOPMENTR01HD029156 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HUNT, JOAN SHERAR · 1992 to 2000
$164k
DECIDUAL CELL/PLACENTAL INTERACTIONSR29HD024212 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HUNT, JOAN SHERAR · 1989 to 1993
–
NICHD NIH HHS HD02528NICHD NIH HHS HD24212NICHD NIH HHS HD29156
6 · The paper itself

Abstract

Tumor necrosis factor-alpha (TNF), a pleiotrophic, multifunctional polypeptide factor, has been reported in both normal and infected human placentas. To identify potential targets for this cytokine, the cells in early and late gestation placentas and extraplacental membranes that express the two TNF receptor (TNF-R) genes, p60 and p80, were identified by using in situ hybridization and immunocytochemistry. Gestation-related, cell lineage-specific differences in steady-state levels of p60 and p80 TNF-R messenger RNA were observed. p60 TNF-R messenger RNA predominated at both early and late stages of gestation, being high in both mesenchymal and trophoblastic cell lineages. By contrast, p80 TNF-R messenger RNA was abundant only in intermittent stretches of first trimester syncytiotrophoblast and term placental mesenchymal cells. Overall, intensities of the TNF-R hybridization signals were stronger in term than in first trimester tissues. Transcription of the two TNF-R genes was confirmed by Northern blot hybridization. Translation was verified in all samples by immunohistology using polyclonal antibodies specific for the receptor proteins. p60 and p80 TNF-R proteins were identified both intracellularly and in maternal and fetal blood. Because TNF-Rs exist in both membrane-bound and soluble forms, the results of this study are consistent with the postulate that placental TNF-R have two critical functions: 1) modulation of TNF utilization by specific placental cell lineages during the course of pregnancy; and 2) protection against excessive TNF produced during infections.

Indexed as

Blotting, NorthernFemaleHumansImmunohistochemistryMembranesMolecular WeightPlacentaPregnancyReceptors, Tumor Necrosis FactorRNA, MessengerTissue DistributionTumor Necrosis Factor-alphaReceptors, Tumor Necrosis FactorRNA, MessengerTumor Necrosis Factor-alpha

Identifiers

PMID8214007
PMCPMC1887066
OpenAlexW203854707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.